Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sutter

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Perfusion|May 6, 2026
From ECPR for refractory cardiac arrest to heart transplant and neurologically intact survivalA Hutin, D Vimpere, J H Raphalen, et al.
The Journal of Infectious Diseases|January 1, 1991
Measles among the Amish: a comparative study of measles severity in primary and secondary cases in householdsR W Sutter, L E Markowitz, J M Bennetch, et al.
The Journal of Infectious Diseases|July 24, 2009
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in IndiaNicholas C Grassly, Hamid Jafari, Sunil Bahl, et al.
Bulletin of the World Health Organization|May 17, 2000
Disease eradication as a public health strategy: a case study of poliomyelitis eradicationR B Aylward, H F Hull, S L Cochi, et al.
The Journal of Infectious Diseases|July 7, 2000
Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradicationK A Hennessey, A Marx, R Hafiz, et al.
The Journal of Infectious Diseases|February 1, 1997
Poliomyelitis in Angola: current status and implications for poliovirus eradication in Southern AfricaH S Izurieta, R J Biellik, O M Kew, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2017
Progress Toward Containment of Poliovirus Type 2 - Worldwide, 2017Nicoletta Previsani, Harpal Singh, Jeanette St Pierre, et al.
Heliyon|March 22, 2018
Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in MadagascarRichter Razafindratsimandresy, Ondrej Mach, Jean-Michel Heraud, et al.
Frontiers in Immunology|October 11, 2017
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization RegistryGrace Macklin, Yi Liao, Marina Takane, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Perfusion|May 6, 2026
From ECPR for refractory cardiac arrest to heart transplant and neurologically intact survivalA Hutin, D Vimpere, J H Raphalen, et al.
The Journal of Infectious Diseases|January 1, 1991
Measles among the Amish: a comparative study of measles severity in primary and secondary cases in householdsR W Sutter, L E Markowitz, J M Bennetch, et al.
The Journal of Infectious Diseases|July 24, 2009
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in IndiaNicholas C Grassly, Hamid Jafari, Sunil Bahl, et al.
Bulletin of the World Health Organization|May 17, 2000
Disease eradication as a public health strategy: a case study of poliomyelitis eradicationR B Aylward, H F Hull, S L Cochi, et al.
The Journal of Infectious Diseases|July 7, 2000
Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradicationK A Hennessey, A Marx, R Hafiz, et al.
The Journal of Infectious Diseases|February 1, 1997
Poliomyelitis in Angola: current status and implications for poliovirus eradication in Southern AfricaH S Izurieta, R J Biellik, O M Kew, et al.
The Journal of Infectious Diseases|January 17, 2019
Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri LankaDeepa Gamage, Ondrej Mach, Samitha Ginige, et al.
MMWR. Morbidity and Mortality Weekly Report|June 23, 2017
Progress Toward Containment of Poliovirus Type 2 - Worldwide, 2017Nicoletta Previsani, Harpal Singh, Jeanette St Pierre, et al.
Heliyon|March 22, 2018
Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in MadagascarRichter Razafindratsimandresy, Ondrej Mach, Jean-Michel Heraud, et al.
Frontiers in Immunology|October 11, 2017
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization RegistryGrace Macklin, Yi Liao, Marina Takane, et al.
Pageof 19